Administration of anti-IL-9 neutralization antibody blocked Th9-induced CD8+ T cells cytotoxicity in both CHB and hepatitis B-related HCC patients (P<0.05, SNK-q tests, Figures 5D–F). The gene discussed is IL9; the disease is hepatocellular carcinoma.